International
Women distressed by an ongoing lack of sexual desire may one day benefit from taking a hormone called 'Kisspeptin', which researchers have shown can change sexual and attraction brain processing. The condition, known as hypoactive sexual desire disorder (HSDD)., affects around 10% of women, but limited treatment options are available. A small trial involving 32 women has found that an intravenous infusion of the hormone can change the way the brain processes sexual attraction and that this in turn can reduce distress and sexual aversion. The authors say this study lays the foundations for clinical applications for kisspeptin in patients with psychosexual disorders.
From:
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Sign In
